Editas: 3Q Earnings Snapshot

November 12, 2019

CAMBRIDGE, Mass. (AP) _ Editas Medicine Inc. (EDIT) on Tuesday reported a loss of $32.9 million in its third quarter.

The Cambridge, Massachusetts-based company said it had a loss of 66 cents per share.

The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 73 cents per share.

The genome editing company posted revenue of $3.8 million in the period, which missed Street forecasts. Three analysts surveyed by Zacks expected $4.1 million.

Editas shares have fallen 10% since the beginning of the year. The stock has decreased 30% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EDIT at https://www.zacks.com/ap/EDIT